Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
A. Fang, S.R. Valluri, M-J. O’Sullivan, R. Maupin, T. Jones, I. Delke & P. Clax. (2012) Safety and Pharmacokinetics of Nelfinavir During the Second and Third Trimesters of Pregnancy and Postpartum. HIV Clinical Trials 13:1, pages 46-59.
Read now
Read now
Tai L. Guo, Dori R. Germolec, Denise M. Roesh & Kimber L. White$suffix/text()$suffix/text(). (2010) Immunomodulation in female B6C3F1 mice following treatment with the HIV protease inhibitor saquinavir for 28 days by gavage. Journal of Immunotoxicology 7:4, pages 289-297.
Read now
Read now
Gail D Anderson. (2006) Using pharmacokinetics to predict the effects of pregnancy and maternal–infant transfer of drugs during lactation. Expert Opinion on Drug Metabolism & Toxicology 2:6, pages 947-960.
Read now
Read now
Luis F. López-Cortés. (2003) Once-Daily Saquinavir-hgc Plus Low-Dose Ritonavir (1200/100 mg) in HIV-Infected Pregnant Women: Pharmacokinetics and Efficacy. HIV Clinical Trials 4:3, pages 227-229.
Read now
Read now
López-Cortés Luis F.. (2003) Once-Daily Saquinavir-hgc Plus Low-Dose Ritonavir (1200/100 mg) in HIV-Infected Pregnant Women: Pharmacokinetics and Efficacy. HIV Clinical Trials 4:3, pages 227-229.
Read now
Read now
Articles from other publishers (40)
Jeremiah D. Momper & Brookie M. Best. 2022. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy
177
202
.
Manoranjenni Chetty, Michael P. Danckwerts & Andrea Julsing. (2020) Prediction of the exposure to a 400-mg daily dose of efavirenz in pregnancy: is this dose adequate in extensive metabolisers of CYP2B6?. European Journal of Clinical Pharmacology 76:8, pages 1143-1150.
Crossref
Crossref
Mohammed Lamorde, Jonathan M. Schapiro, David Burger & David J. Back. (2014) Antiretroviral drugs for prevention of mother-to-child transmission. AIDS 28:17, pages 2551-2563.
Crossref
Crossref
Shelley A. McCormack & Brookie M. Best. (2014) Protecting the Fetus Against HIV Infection: A Systematic Review of Placental Transfer of Antiretrovirals. Clinical Pharmacokinetics 53:11, pages 989-1004.
Crossref
Crossref
Anders Helldén & Parvaz Madadi. (2013) Pregnancy and pharmacogenomics in the context of drug metabolism and response. Pharmacogenomics 14:14, pages 1779-1791.
Crossref
Crossref
Nisha Andany & Mona R. Loutfy. (2013) HIV Protease Inhibitors in Pregnancy. Drugs 73:3, pages 229-247.
Crossref
Crossref
Brookie M. Best. 2013. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy
173
199
.
Kajal Buckoreelall, Tim R. Cressey & Jennifer R. King. (2012) Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy. Clinical Pharmacokinetics 51:10, pages 639-659.
Crossref
Crossref
Maria Martinez-Rebollar, Montserrat Lonca, Iñaki Perez, Dolors Soy, Mercè Brunet, Rosa Martin, Oriol Coll, Sandra Hernandez, Montserrat Laguno, Ana Milinkovic, Maria Larrousse, Marta Calvo, Jose L Blanco, Esteban Martínez, Jose M Gatell & Josep Mallolas. (2011) Pharmacokinetic Study of Saquinavir 500 mg Plus Ritonavir (1000/100 mg Twice a Day) in HIV-Positive Pregnant Women. Therapeutic Drug Monitoring 33:6, pages 772-777.
Crossref
Crossref
F Conradie, C Zorrilla, D Josipovic, M Botes, O Osiyemi, E Vandeloise, T Eley, M Child, R Bertz, W Hu, V Wirtz & D McGrath. (2011) Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. HIV Medicine 12:9, pages 570-579.
Crossref
Crossref
Mark Mirochnick, Brookie M. Best & Diana F. Clarke. (2010) Antiretroviral Pharmacology: Special Issues Regarding Pregnant Women and Neonates. Clinics in Perinatology 37:4, pages 907-927.
Crossref
Crossref
Mohammed Lamorde, Pauline Byakika-Kibwika, Violet Okaba-Kayom, John P Flaherty, Marta Boffito, Rhoda Namakula, Mairin Ryan, Clemensia Nakabiito, David J Back, Saye Khoo, Concepta Merry & Kimberly K Scarsi. (2010) Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1-Seropositive Ugandan Women. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:3, pages 345-350.
Crossref
Crossref
Huixia Zhang, Xiaohui Wu, Suresh Babu Naraharisetti, Francisco Chung, Dale Whittington, Ahmad Mirfazaelian & Jashvant D. Unadkat. (2009)
Pregnancy Does Not Increase CYP3A or P-Glycoprotein Activity in the Non-Human Primate,
Macaca nemestrina
. Journal of Pharmacology and Experimental Therapeutics 330:2, pages 586-595.
Crossref
Crossref
Abhishek Gulati & Phillip M. Gerk. (2009) Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy. Journal of Pharmaceutical Sciences 98:7, pages 2317-2335.
Crossref
Crossref
Huixia Zhang, Xiaohui Wu, Francisco Chung, Suresh Babu Naraharisetti, Dale Whittington, Ahmad Mirfazaelian & Jashvant D. Unadkat. (2009)
As in Humans, Pregnancy Increases the Clearance of the Protease Inhibitor Nelfinavir in the Nonhuman Primate
Macaca nemestrina
. Journal of Pharmacology and Experimental Therapeutics 329:3, pages 1016-1022.
Crossref
Crossref
Arlene D. Bardeguez. 2009. HIV/AIDS in U.S. Communities of Color. HIV/AIDS in U.S. Communities of Color
103
132
.
Nils von Hentig, Gabi Nisius, Tessa Lennemann, Pavel Khaykin, Christoph Stephan, Errol Babacan, Schlomo Staszewski, Michael Kurowski, Sebastian Harder & Annette Haberl. (2008) Pharmacokinetics, Safety and Efficacy of Saquinavir/ Ritonavir 1,000/100 Mg Twice Daily as HIV Type-1 Therapy and Transmission Prophylaxis in Pregnancy. Antiviral Therapy 13:8, pages 1039-1046.
Crossref
Crossref
Silvia Baroncelli, Paola Villani, Marco Floridia, Maria F Pirillo, Clementina M Galluzzo, Maria Cusato, Roberta Amici, Carmela Pinnetti, Francesca Sabbatini, Atim Molinari, Enrica Tamburrini & Mario Regazzi. (2008) Trough Concentrations of Lopinavir, Nelfinavir, and Nevirapine With Standard Dosing in Human Immunodeficiency Virus-Infected Pregnant Women Receiving 3-Drug Combination Regimens. Therapeutic Drug Monitoring 30:5, pages 604-610.
Crossref
Crossref
Matthieu Roustit, Malik Jlaiel, Pascale Leclercq & Françoise Stanke-Labesque. (2008) Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women. British Journal of Clinical Pharmacology 66:2, pages 179-195.
Crossref
Crossref
Arlene D Bardeguez, Jane C Lindsey, Maureen Shannon, Ruth E Tuomala, Susan E Cohn, Elizabeth Smith, Alice Stek, Shelly Buschur, Amanda Cotter, Linda Bettica & Jennifer S Read. (2008) Adherence to Antiretrovirals Among US Women During and After Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:4, pages 408-417.
Crossref
Crossref
Brookie M Best & Edmund V Capparelli. (2008) Implications of gender and pregnancy for antiretroviral drug dosing. Current Opinion in HIV and AIDS 3:3, pages 277-282.
Crossref
Crossref
EV Capparelli, F Aweeka, J Hitti, A Stek, C Hu, SK Burchett, B Best, E Smith, JS Read, H Watts, S Nachman, EM Thorpe, SA Spector, E Jimenez, WT Shearer, M Foca & M Mirochnick. (2008) Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Medicine 9:4, pages 214-220.
Crossref
Crossref
Carmen D. Zorrilla, Russell Van Dyke, Arlene Bardeguez, Edward P. Acosta, Betsy Smith, Michael D. Hughes, Sharon Huang, D. Heather Watts, Barbara Heckman, Eleanor Jiménez, George McSherry & Lynne Mofenson. (2007) Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants. Antimicrobial Agents and Chemotherapy 51:6, pages 2208-2210.
Crossref
Crossref
Luis F Lopez-Cortes, Rosa Ruiz-Valderas, Antonio Rivero, Angela Camacho, Manuel Marquez-Solero, Jesus Santos, Milagros García-Lazaro, Pompeyo Viciana, Jesus Rodriguez-Baños & Antonio Ocampo. (2007) Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy. Therapeutic Drug Monitoring 29:2, pages 171-176.
Crossref
Crossref
Alice M Stek, Mark Mirochnick, Edmund Capparelli, Brookie M Best, Chengcheng Hu, Sandra K Burchett, Carol Elgie, Diane T Holland, Elizabeth Smith, Ruth Tuomala, Amanda Cotter & Jennifer S Read. (2006) Reduced lopinavir exposure during pregnancy. AIDS 20:15, pages 1931-1939.
Crossref
Crossref
Andrea Gingelmaier, Michael Kurowski, Ralph Kästner, Josef Eberle, Ioannis Mylonas, Bernd H Belohradsky, Klaus Friese & Thomas A Grubert. (2006) Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery. AIDS 20:13, pages 1737-1743.
Crossref
Crossref
Anita A. Mathias, Lillian Maggio-Price, Yurong Lai, Anshul Gupta & Jashvant D. Unadkat. (2006) Changes in Pharmacokinetics of Anti-HIV Protease Inhibitors during Pregnancy: The Role of CYP3A and P-glycoprotein. Journal of Pharmacology and Experimental Therapeutics 316:3, pages 1202-1209.
Crossref
Crossref
D Heather Watts. (2006) Treating HIV During Pregnancy. Drug Safety 29:6, pages 467-490.
Crossref
Crossref
Susan Cu-Uvin, Arlene Bardeguez & Carla Chibwesha. 2006. Reverse Transcriptase Inhibitors in HIV/AIDS Therapy. Reverse Transcriptase Inhibitors in HIV/AIDS Therapy
425
470
.
Esteve Ribera, Luis Fernando López-Cortés, Vicente Soriano, José Luis Casado & Josep Mallolas. (2005) Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?. Enfermedades Infecciosas y Microbiología Clínica 23, pages 55-67.
Crossref
Crossref
Esteve Ribera, Luis Fernando López-Cortés, Vicente Soriano, José Luis Casado & Josep Mallolas. (2005) Monitorización terapéutica y cociente inhibitorio de los fármacos antirretrovirales: ¿son aplicables a nuestra realidad?. Enfermedades Infecciosas y Microbiología Clínica 23, pages 41-54.
Crossref
Crossref
Jennifer J. Kiser, Peter L. Anderson & John G. Gerber. (2005) Therapeutic drug monitoring: Pharmacologic considerations for antiretroviral drugs. Current HIV/AIDS Reports 2:2, pages 61-67.
Crossref
Crossref
Edmund Capparelli, Natella Rakhmanina & Mark Mirochnick. (2005) Pharmacotherapy of perinatal HIV. Seminars in Fetal and Neonatal Medicine 10:2, pages 161-175.
Crossref
Crossref
Gail D Anderson. (2005) Pregnancy-Induced Changes in Pharmacokinetics. Clinical Pharmacokinetics 44:10, pages 989-1008.
Crossref
Crossref
Gail D. Anderson. (2005) Sex and Racial Differences in Pharmacological Response: Where Is the Evidence? Pharmacogenetics, Pharmacokinetics, and Pharmacodynamics. Journal of Women's Health 14:1, pages 19-29.
Crossref
Crossref
J. F. J. B. Nellen, I. Schillevoort, F. W. N. M. Wit, A. S. Bergshoeff, M. H. Godfried, K. Boer, J. M. A. Lange, D. M. Burger & J. M. Prins. (2004) Nelfinavir Plasma Concentrations Are Low during Pregnancy. Clinical Infectious Diseases 39:5, pages 736-740.
Crossref
Crossref
Hélène Chappuy, Jean-Marc Tréluyer, Elisabeth Rey, Jérôme Dimet, Maria Fouché, RN, Ghislaine Firtion, Gérard Pons & Laurent Mandelbrot. (2004) Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus. American Journal of Obstetrics and Gynecology 191:2, pages 558-562.
Crossref
Crossref
Edward P. Acosta, Arlene Bardeguez, Carmen D. Zorrilla, Russell Van Dyke, Michael D. Hughes, Sharon Huang, Lisa Pompeo, Alice M. Stek, Jane Pitt, D. Heather Watts, Elizabeth Smith, Eleanor Jiménez & Lynne Mofenson. (2004) Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant Women. Antimicrobial Agents and Chemotherapy 48:2, pages 430-436.
Crossref
Crossref
Mark Mirochnick & Edmund Capparelli. (2004) Pharmacokinetics of Antiretrovirals in Pregnant Women. Clinical Pharmacokinetics 43:15, pages 1071-1087.
Crossref
Crossref
Bradley W Kosel, Karen P Beckerman, Sandra Hayashi, Masato Homma & Francesca T Aweeka. (2003) Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women. AIDS 17:8, pages 1195-1199.
Crossref
Crossref